Here are four points:
1. Xtant’s total short interest was 79,800 shares in May as published by the Financial Industry Regulatory Authority.
2. Xtant Medical has underperformed the S&P500 by 43.12 percent.
3. The company’s average volume is 29,800 shares.
4. The company has a market cap of $21.56 million.
More articles on devices:
FDA clears First Ray’s Stealth Staple System — 5 highlights
Medtronic names Karen Parkhill EVP, CFO: 5 key notes
Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
